chr3-12572132-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014160.5(MKRN2):c.401G>A(p.Ser134Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014160.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MKRN2 | NM_014160.5 | c.401G>A | p.Ser134Asn | missense_variant | 4/8 | ENST00000170447.12 | NP_054879.3 | |
MKRN2 | NM_001271707.2 | c.272G>A | p.Ser91Asn | missense_variant | 3/7 | NP_001258636.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MKRN2 | ENST00000170447.12 | c.401G>A | p.Ser134Asn | missense_variant | 4/8 | 1 | NM_014160.5 | ENSP00000170447 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251068Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135722
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461798Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 727202
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 28, 2023 | The c.401G>A (p.S134N) alteration is located in exon 4 (coding exon 4) of the MKRN2 gene. This alteration results from a G to A substitution at nucleotide position 401, causing the serine (S) at amino acid position 134 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at